Nanotechnology contributions to the pharmacotherapy of pediatric HIV: A dual scientific and ethical challenge and a still pending agenda

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)833-837
Number of pages5
JournalNanomedicine
Volume5
Issue number6
DOIs
StatePublished - Aug 2010
Externally publishedYes

Keywords

  • cost-viable liquid formulations
  • efavirenz
  • ethical affordability
  • neglected diseases
  • pediatric HIV
  • scalable liquid formulations

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • General Materials Science

Cite this